van Rensburg, D J <br/><br/>
Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin.  [electronic resource] 

 -  Chemotherapy  Jul 2005 
 - 186-92 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-3157 
<br/><br/><label>Standard No.: </label>10.1159/000086576  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Anti-Bacterial Agents--therapeutic use<br/>Community-Acquired Infections--drug therapy<br/>Double-Blind Method<br/>Erythromycin--pharmacology<br/>Female<br/>Humans<br/>Ketolides--therapeutic use<br/>Male<br/>Middle Aged<br/>Penicillin Resistance<br/>Pneumonia, Pneumococcal--drug therapy<br/>Treatment Outcome